Steve Miller - Dec 5, 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Op. & Scientific Officer
Signature
/s/ Steve Miller
Stock symbol
CPRX
Transactions as of
Dec 5, 2023
Transactions value $
-$569,600
Form type
4
Date filed
12/7/2023, 05:00 PM
Previous filing
May 12, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale -$570K -40K -5.82% $14.24 647K Dec 5, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to fund the exercise price and tax withholding associated with the exercise of a stock option that will expire on January 3, 2024 and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in a range from $14.23 to $14.26 per share.